DexComDXCM
NASDAQMedical Devices
No cached AI snapshot yet for DXCM.
Be the first to run a multi-agent analysis on this ticker.
Key Stats
11,100 employees385.87M shares outstandinglisted 2005-04-14
Next earnings ~May 5, 2026
About DexCom
DexCom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to provide integration with insulin pumps from Insulet and Tandem for automatic insulin delivery. DexCom's CGMs are available through medical equipment distributors as well as retail pharmacies.
Latest News
Showing market-wide stock news
Dexcom's CFO Jereme Sylvain To Take Addl. Role Of COO
DexCom expands CFO’s role to COO
Stock Market Today (Sept. 16, 2026): Nasdaq futures edge higher ahead of Fed decision
Why is the US Dollar firm when the Federal Reserve hike is already fully priced in?
5% Treasury yields mean America’s debt bill just got a lot bigger
US30 tests 52,140 as 5% Treasury yields rewrite the equity math
Related Stocksin Medical Devices
Ready to see the live AI view on DXCM?
Launch a real-time multi-agent room — Claude, GPT, Gemini, DeepSeek, Grok, and Qwen analyzing DXCM side-by-side with live signals.